These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 8529066)

  • 1. Metabolism of dopamine prodrug, docarpamine.
    Yoshikawa M; Nishiyama S; Takaiti O
    Hypertens Res; 1995 Jun; 18 Suppl 1():S211-3. PubMed ID: 8529066
    [TBL] [Abstract][Full Text] [Related]  

  • 2. First pass metabolism and in vitro metabolism of a new orally active dopamine prodrug, N-(N-acetyl-L-methionyl)-O,O-bis(ethoxycarbonyl)dopamine in dogs.
    Yoshikawa M; Nishiyama S; Endo H; Togo Y; Takaiti O
    Drug Metab Dispos; 1991; 19(5):960-5. PubMed ID: 1686243
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bioavailability and pharmacokinetics of an oral dopamine prodrug in dogs.
    Murata K; Noda K; Kohno K; Samejima M
    J Pharm Sci; 1989 Oct; 78(10):812-4. PubMed ID: 2600785
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of a new orally active dopamine prodrug, docarpamine, on refractory ascites: a pilot study.
    Funasaki T; Tsutsumi M; Takase S; Tsuchishima M; Ueshima Y; Urashima S; Shimanaka K; Itoh T; Kawahara H
    Am J Gastroenterol; 1999 Sep; 94(9):2475-81. PubMed ID: 10484011
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetic analysis of absorption and metabolism of dopamine and a dopamine prodrug in dogs.
    Murata K; Noda K; Kohno K; Samejima M
    Biopharm Drug Dispos; 1990 Mar; 11(2):149-56. PubMed ID: 2328300
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of docarpamine, a novel orally active dopamine prodrug, on the formation of free and sulfoconjugated dopamine in patients who underwent cardiac surgery.
    Tano K; Yoshizumi M; Kitagawa T; Hori T; Kitaichi T; Itoh K; Katoh I
    Life Sci; 1997; 61(15):1469-78. PubMed ID: 9328226
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of cardiorenal and emetic effects of dopamine prodrugs docarpamine (TA-870) and levodopa in dogs.
    Nishiyama S; Kanno K; Yamaguchi I
    J Pharmacobiodyn; 1991 Mar; 14(3):120-5. PubMed ID: 1679131
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of docarpamine on hemodynamics after open heart surgery in children.
    Watarida S; Shiraishi S; Sugita T; Katsuyama K; Nakajima Y; Yamamoto R; Yamamoto Y; Imura M; Hirokawa R; Mori A
    Ann Thorac Cardiovasc Surg; 2000 Apr; 6(2):106-9. PubMed ID: 10870004
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metabolism of a new orally active dopamine prodrug, N-(N-acetyl-L-methionyl)-O,O-bis(ethoxycarbonyl)dopamine (TA-870) and dopamine after oral administration to rats and dogs.
    Yoshikawa M; Endo H; Komatsu K; Sugawara Y; Takaiti O
    J Pharmacobiodyn; 1990 Apr; 13(4):246-53. PubMed ID: 2384858
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plasma concentration and acute clinical effects of docarpamine, orally active dopamine prodrug, in infants.
    Tomita H; Fuse S; Chiba S
    Acta Paediatr Jpn; 1996 Oct; 38(5):440-3. PubMed ID: 8942000
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative study on the disposition of a new orally active dopamine prodrug, N-(N-acetyl-L-methionyl)-O,O-bis(ethoxycarbonyl)dopamine (TA-870) and dopamine hydrochloride in rats and dogs.
    Yoshikawa M; Endo H; Otsuka M; Yamaguchi I; Harigaya S
    Drug Metab Dispos; 1988; 16(5):754-8. PubMed ID: 2906602
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of docarpamine, a dopamine pro-drug, on blood pressure and catecholamine levels in spontaneously hypertensive rats.
    Sanada H; Asico LD; Shigetomi S; Tanaka K; Niimura S; Watanabe H; Goldstein DS; Felder RA
    Clin Exp Hypertens; 2000 May; 22(4):419-29. PubMed ID: 10830753
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oral administration of the dopamine prodrug docarpamine shortens need for drip infusion of dopamine in patients with low cardiac output syndrome after cardiac surgery.
    Matsubayashi K; Ueda Y; Ogino H; Sugita T; Sakakibara Y; Matsuyama K; Nomoto T
    Thorac Cardiovasc Surg; 1999 Dec; 47(6):352-6. PubMed ID: 10670791
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bioavailability and pharmacokinetics of oral dopamine in dogs.
    Murata K; Noda K; Kohno K; Samejima M
    J Pharm Sci; 1988 Jul; 77(7):565-8. PubMed ID: 3171942
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment for ovarian hyperstimulation syndrome using an oral dopamine prodrug, docarpamine.
    Tsunoda T; Shibahara H; Hirano Y; Suzuki T; Fujiwara H; Takamizawa S; Ogawa S; Motoyama M; Suzuki M
    Gynecol Endocrinol; 2003 Aug; 17(4):281-6. PubMed ID: 14503971
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Disposition of a new orally active dopamine prodrug, N-(N-acetyl-L-methionyl)-O,O-bis(ethoxycarbonyl) dopamine (TA-870) in humans.
    Yoshikawa M; Endo H; Komatsu K; Fujihara M; Takaiti O; Kagoshima T; Umehara M; Ishikawa H
    Drug Metab Dispos; 1990; 18(2):212-7. PubMed ID: 1971575
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A novel orally active dopamine prodrug TA-870. I. Renal and cardiovascular effects and plasma levels of free dopamine in dogs and rats.
    Yamaguchi I; Nishiyama S; Akimoto Y; Yoshikawa M; Nakajima H
    J Cardiovasc Pharmacol; 1989 Jun; 13(6):879-86. PubMed ID: 2484082
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro and in vivo evaluations of the metabolism, pharmacokinetics, and bioavailability of ester prodrugs of L-767,679, a potent fibrinogen receptor antagonist: an approach for the selection of a prodrug candidate.
    Prueksaritanont T; Gorham LM; Breslin MJ; Hutchinson JH; Hartman GD; Vyas KP; Baillie TA
    Drug Metab Dispos; 1997 Aug; 25(8):978-84. PubMed ID: 9280406
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relative contribution of the gut, liver, and lung to the first-pass hydrolysis (bioactivation) of orally administered 14C-fosinopril sodium in dogs. In vivo and in vitro studies.
    Morrison RA; Singhvi SM; Peterson AE; Pocetti DA; Migdalof BH
    Drug Metab Dispos; 1990; 18(2):253-7. PubMed ID: 1971582
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ibopamine, an orally active dopamine-like drug: metabolism and pharmacokinetics in dogs.
    Pocchiari F; Pataccini R; Castelnovo P; Longo A; Paro M; Casagrande C
    Arzneimittelforschung; 1986 Feb; 36(2A):341-4. PubMed ID: 3707646
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.